Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PNPLA3 is a triglyceride lipase that mobilizes polyunsaturated fatty acids to facilitate hepatic secretion of large-sized very low-density lipoprotein. | Nat Commun | 2024 | 38844467 | PubTator, text mining | PubMed |
| Fine-scale contemporary recombination variation and its fitness consequences in adaptively diverging stickleback fish. | Nat Ecol Evol | 2024 | 38839849 | PubTator, text mining | PubMed |
| Use of PNPLA3, TM6SF2, and HSD17B13 for detection of fibrosis in MASLD in the general population. | Clin Res Hepatol Gastroenterol | 2024 | 38830575 | PubTator, text mining | PubMed |
| The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes. | Aliment Pharmacol Ther | 2024 | 38825972 | PubTator, text mining | PubMed |
| Coix Sprouts Affect Triglyceride Metabolism in Huh7 Cells and High-Fat Diet-Induced Obese Mice. | J Med Food | 2024 | 38808469 | PubTator, text mining | PubMed |
| Mesenteric panniculitis associated with non-alcoholic fatty liver disease: A case series. | J Pak Med Assoc | 2024 | 38783455 | PubTator, text mining | PubMed |
| The health care experience of adults with metabolic dysfunction-associated steatohepatitis and influence of PNPLA3: A qualitative study. | Hepatol Commun | 2024 | 38780312 | PubTator, text mining | PubMed |
| PNPLA3 risk allele is associated with risk of hepatocellular carcinoma but not decompensation in compensated cirrhosis. | Hepatol Commun | 2024 | 38780253 | PubTator, text mining | PubMed |
| Integrating genetic and socioeconomic data to predict the progression of nonalcoholic fatty liver disease. | Am J Biol Anthropol | 2024 | 38778456 | PubTator, text mining | PubMed |
| Non-invasive biomarkers prognostic of decompensation events in NASH cirrhosis: a systematic literature review. | J Mol Med (Berl) | 2024 | 38753041 | PubTator, text mining | PubMed |
| Comprehensive variant analysis of phospholipase A2 superfamily genes in large Chinese Parkinson' s disease cohorts. | Mech Ageing Dev | 2024 | 38750970 | PubTator, text mining | PubMed |
| PNPLA3, Obesity, and Heavy Alcohol Use in Cirrhosis Patients May Exert a Synergistic Increase Hepatocellular Carcinoma Risk. | Clin Gastroenterol Hepatol | 2024 | 38729396 | PubTator, text mining | PubMed |
| Liver Fibrosis Assessed Via Noninvasive Tests Is Associated With Incident Heart Failure in a General Population Cohort. | Clin Gastroenterol Hepatol | 2024 | 38723982 | PubTator, text mining | PubMed |
| DiSMVC: a multi-view graph collaborative learning framework for measuring disease similarity. | Bioinformatics | 2024 | 38715444 | PubTator, text mining | PubMed |
| Comparison of Wild-Type and High-risk PNPLA3 variants in a Human Biomimetic Liver Microphysiology System for Metabolic Dysfunction-associated Steatotic Liver Disease Precision Therapy. | bioRxiv | 2024 | 38712213 | PubTator, text mining | PubMed |
| A patient-based iPSC-derived hepatocyte model of alcohol-associated cirrhosis reveals bioenergetic insights into disease pathogenesis. | Nat Commun | 2024 | 38693144 | PubTator, text mining | PubMed |
| Genome-wide association study of metabolic dysfunction-associated fatty liver disease in a Korean population. | Sci Rep | 2024 | 38679617 | PubTator, text mining | PubMed |
| The Role of PNPLA3_rs738409 Gene Variant, Lifestyle Factors, and Bioactive Compounds in Nonalcoholic Fatty Liver Disease: A Population-Based and Molecular Approach towards Healthy Nutrition. | Nutrients | 2024 | 38674929 | PubTator, text mining | PubMed |
| Relevance of PNPLA3, TM6SF2, HSD17B13, and GCKR Variants to MASLD Severity in an Egyptian Population. | Genes (Basel) | 2024 | 38674389 | PubTator, text mining | PubMed |
| A genome-first approach to variants in MLXIPL and their association with hepatic steatosis and plasma lipids. | Hepatol Commun | 2024 | 38668731 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=20